A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma.
about
A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase II trial of small-dose ...... atients with multiple myeloma.
@en
A phase II trial of small-dose ...... atients with multiple myeloma.
@nl
type
label
A phase II trial of small-dose ...... atients with multiple myeloma.
@en
A phase II trial of small-dose ...... atients with multiple myeloma.
@nl
prefLabel
A phase II trial of small-dose ...... atients with multiple myeloma.
@en
A phase II trial of small-dose ...... atients with multiple myeloma.
@nl
P2093
P2860
P1476
A phase II trial of small-dose ...... atients with multiple myeloma.
@en
P2093
Akari Hashimoto
Akihito Fujimi
Ayumi Tatekoshi
Hiroto Horiguchi
Hiroyuki Kuroda
Junji Kato
Kazuyuki Murase
Kohichi Takada
Masahiro Yoshida
P2860
P2888
P304
P356
10.1007/S00280-016-3163-Y
P577
2016-10-13T00:00:00Z